3. Health meets Future Summit

12. Juni 2019
Frankfurt am Main / Offenbach

Die Digitalisierung hat längst auch den Gesundheitssektor erreicht. Der diesjährige Health meets Future Summit trägt dieser Transformation der Gesundheitsbranche Rechnung und widmet sich digitalen Innovationen in der Medizin, der Pharmaindustrie, den Life Sciences und der Biotechnologie.
Der Summit zeigt aktuelle Erkenntnisse aus Forschung und Entwicklung sowie neue digitale Geschäftsmodelle und deren Wachstumspotenziale auf.
Internationale Vordenker und Entscheidungsträger diskutieren u.a. folgende zentrale Fragen zur digitalen Transformation:

  • Richtlinien und Rahmenbedingungen: Welches sind die Haupttreiber der Transformation und welchen Rahmen benötigt der digitale Gesundheitsmarkt?
  • Datenanalyse und Künstliche Intelligenz: Wie können wir Gesundheitsdaten nutzen und monetarisieren und datengetriebene Geschäftsmodelle aufbauen?
  • Transformation des Patientenerlebnisses: Welches sind die innovativsten und disruptivsten Themen im »Internet of You«?

 

Die Konferenzsprache ist Englisch.

Der Hashtag zur Veranstaltung lautet #HealthSummit.

Sprecher (Auszug)

Satschin Bansal

Satschin Bansal

Satschin Bansal

Digital Health MedTech Executive

Satschin is Senior Director for Digital Health and Value-added Solutions at Zimmer Biomet, a worldwide leader in musculoskeletal healthcare with global sales of approx. USD 8Bn and 18’000 employees.
He has been a key driver in transforming the company from a pure implant manufacturer to a total solution provider and developing a Digital Health business unit. As part of this, he is responsible to identify, develop and commercialize Connected Solutions, which help Hospitals to create competitive advantage, improve operational efficiencies and increase patient satisfaction. He is well-rounded speaker and has been presenting at many conferences on the topic of Digital Transformation and changing landscape within the Medtech space.
Satschin joined Zimmer in 2007 and worked over the past 12 years in various strategic management roles in the area of Strategic Marketing, Business Development, Product Management and Sales. Prior to joining Zimmer, he worked within Marketing at Procter & Gamble. He holds a Master degree in International Management & Law from the University of St.Gallen (Switzerland) and is a visiting instructor for International Marketing at various Executive MBA Programs.

Dusan Beblavy

Dušan Beblavý

Dušan Beblavý

Chief Technical Officer Medical Technologies for Europe, GlobalLogic

Gunjan Bhardwaj

Dr. Gunjan Bhardwaj

Dr. Gunjan Bhardwaj

Founder and CEO, Innoplexus AG

Dr. Gunjan Bhardwaj, Founder and CEO of Innoplexus AG, a leading global AI champion with more than 90 patent applications in Artificial Intelligence, Machine Learning, and Blockchain technologies. Gunjan himself is the author of 12 patent applications. He has authored several publications in the Harvard Business Review, MIT Sloan Review, the Journal of Tumor Medicine and Prevention, the Journal of Service Research and the International Journal of Innovation Management, as well as the book Branding in Emerging Markets. He regularly publishes in Forbes, Pharma forum and other blogs. He appeared as a keynote speaker at various international life science events in healthcare.

Dr. Philipp Diesinger

Dr. Philipp Diesinger

Dr. Philipp Diesinger

Head of Global Data Science, Boehringer Ingelheim

Dr. Diesinger ist ein leidenschaftlicher Datenwissenschaftler, der fest davon überzeugt ist, dass die datengesteuerte wissenschaftliche Problemlösung Industrie und Wirtschaft in großem Umfang verändern wird.

Er promovierte in theoretischer Physik und begann seine Karriere als Datenwissenschaftler 2009 als Forscher am Massachusetts Institute of Technology. Ab 2012 arbeitete er für verschiedene Unternehmen und Start-ups und wechselte 2014 zu SAP Global Data Science Consulting. Bei SAP entwickelte er intelligente Data-Science-Lösungen für global operierende Kunden und skalierte die Life-Science-Engagements des Data-Science-Teams.

Dr. Diesinger kam im November 2015 als Global Head of Data Science zu Boehringer Ingelheim und leitet und entwickelt seitdem die Data-Science-Fähigkeiten. Die künstliche Intelligenzlösungen, an denen Dr. Diesinger und sein Team gearbeitet haben, ermöglichten es Boehringer Ingelheim, in Schlüsselbereichen branchenführende Positionen einzunehmen.

Prof. Dr. Michael Forsting

Prof. Dr. Michael Forsting

Prof. Dr. Michael Forsting

Director, Institute of Diagnostic and Interventional Radiology and Neuroradiology, Essen University Hospital

Professor Dr. med. Michael Forsting is Medical Chairman of Central IT at the University Hospital Essen and Chairman of Diagnostic and Interventional Radiology and Neuroradiology at the University Hospital Essen. His scientific work focuses on experimental and clinical research on stroke, MR imaging of cerebral disorder and brain tumors and endovascular therapy of intracranial vascular malformations. He is Vice Dean (Research) of the Medical Faculty of the University Hospital Essen and Member of the Leopoldina (National Academy of Sciences). He has published more than 500 original papers.

Prof. Dr. Robin Haring

Prof. Dr. Robin Haring

Prof. Dr. Robin Haring

Professor of Public Health, European University of Applied Sciences (EUFH), Faculty of Applied Public Health

Prof Haring is an expert in cardiovascular epidemiology and public health. He studied demography at the University of Rostock (Diploma, 2006), completed his PhD at the University of Greifswald (2010) and spend his Post-Doc at Boston University in the Framingham Heart Study (2011). After his habilitation on the role of testosterone as men’s health biomarker (2013) he was appointed 2014 as full professor at the European University of Applied Sciences (EUFH) and 2016 as adjunct professor at Monash University, School of Public Health and Preventive Medicine. Prof Haring actively publishes on the challenges and impact of digital healthcare on public health.

Anders Hedegaard

Anders Hedegaard

Anders Hedegaard

CEO, Rodenstock Group

Anders Hedegaard was born in 1960 and is a Danish citizen.

Anders Hedegaard is the CEO of the Rodenstock Group, a global leader in eye health innovation and manufacturer of ophthalmic lenses and frames.

Anders has a Master of Science in Chemical Engineering from the Technical University of Denmark.
From 1991 to 2000 he worked at Novo Nordisk A/S in various marketing and management roles with increasing responsibility. In 2000, Anders was appointed Group Vice President and member of the executive group management in Foss A/S. From 2002 to 2007 he was Executive Vice President, Business Operations & International Marketing at ALK-Abelló A/S. From 2007 to 2014, Anders was CEO of the listed Danish biotechnology company Bavarian Nordic A/S.
Before joining the Rodenstock Group, Anders served as the President and CEO of GN Hearing, one of the world’s leading manufacturers of hearing aids.
Anders brings a unique set of capabilities and values to the executive manage-ment within global leadership, marketing and sales.

Jan Horvat

Jan Horvat

Jan Horvat

Senior Business Development Manager, Zühlke Technology Group AG

Joining Zühlke in 2016 Jan Horvat is acting as Industry Lead – Healthcare and Life Science, responsible for strategic Business Development for Digital Business Innovation (New Digital Business Models, IoT, Industry 4.0, AI, Blockchain) focused on the Pharmaceutical Industry. He has a long track record in several strategic and operational management positions leading international product and software development alliances in various tech-industries (pharmaceutical, machinery, aerospace, automotive). He holds a Dipl. Wirtschaftsing. (FH) degree in Industrial Engineering and Management studying at University of Technology Mittelhessen and Universidad Politécnica de Madrid.

Stephanie Kaiser

Stephanie Kaiser

Stephanie Kaiser

Gründerin und Geschäftsführerin, Heartbeat Labs

Als Gründerin und Geschäftsführerin der Digital Health-Plattform Heartbeat Labs treibt Stephanie Kaiser die Digitalisierung des Gesundheitswesens voran. Mit digitalen Lösungen möchte die erfahrene Produktmanagerin den Zugang zur Gesundheitsversorgung erleichtern und verbessern. Sie hat über 12 Jahre Erfahrung im Aufbau digitaler Produkte und war unter anderem an der Weiterentwicklung der Zyklustracking-App Clue beteiligt. Seit 2018 ist sie ehrenamtliches Mitglied im Digitalrat der Bundesregierung.

Leif Pedersen

Leif Pedersen

Leif Pedersen

BIOVIA CEO, Dassault Systèmes

Leif Pedersen is a seasoned software industry executive at Dassault Systèmes with more than 25 years of product and marketing experience supporting multiple vertical markets and a proven track record of building high-performance teams. Before joining BIOVIA as CEO, Mr. Pedersen served as executive vice president at Innovative Interfaces, senior vice president of marketing, product management and corporate development at Accelrys (now BIOVIA), and vice president at Siemens and at UGS managing business strategies. Prior to UGS, Mr. Pedersen held executive leadership positions with Vignette Corp., Novell Inc., Computer Associates and Oracle Corporation.

Iris Ploeger

Iris Plöger

Iris Plöger

Mitglied der Hauptgeschäftsführung, BDI e.V.

Iris Plöger wurde 1971 in Hamburg geboren. Sie studierte Rechtswissenschaften in Kiel und dem Vereinigten Königreich. Im Anschluss war sie als Wissenschaftliche Mitarbeiterin am Institut für Wirtschafts- und Steuerrecht der Christian-Albrechts-Universität zu Kiel tätig. Nach dem Zweiten Juristischen Staatsexamen arbeitete Iris Plöger ab 2000 als Rechtsanwältin mit Schwerpunkt Wettbewerbs- und IT-Recht in der internationalen Wirtschaftskanzlei Freshfields Bruckhaus Deringer.

2004 wechselte sie in die Rechtsabteilung des BDI und übernahm 2015 die Leitung der Abteilung Digitalisierung und industrielle Wertschöpfungsstrukturen im BDI. Seit 2016 leitete sie dann im BDI die Abteilung Digitalisierung, Innovation und Gesundheitswirtschaft.

Seit April 2017 ist Iris Plöger Mitglied der Hauptgeschäftsführung des BDI.

Karin Reichl

Karin Reichl

Karin Reichl

Managing Director, Health Angels GmbH

Karin studied communications science and graduated from the German School of Journalism in Munich, Germany. In 1997 she founded the strategic publication planning agency pluspool, which she brought to TBWA in 2010. After three and a half years as Managing Director at TBWA Germany, she then transferred to greyhealth group, where she spent four years as CEO. Since 2018, she has been the managing director of health angels, the healthcare agency within the Hirschen Group. Karin brings with her a long list of international clients such as Pfizer, Roche, Bayer, Olympus, GE Healthcare, Santen, Ipsen, Merck, Fresenius Kabi, Janssen and Colgate, to name just a few. Her fields of expertise range from andrology and virology to blockbuster brands and ultra rare diseases. For her, healthcare communication has to be unusual, challenging, fascinating, unmatched, grandiose and, above all, logical. Because in the end, it has to help people while changing the way they think.

Karin Reichl

Dr. Stefan Rueping

Dr. Stefan Rüping

Dr. Stefan Rüping

Head of Big Data Analytics, Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS

Dr. Axel Schumacher

Dr. Axel Schumacher

Dr. Axel Schumacher

Founder & Chief Scientific Officer, Shivom

Axel Schumacher verfügt über mehr als 25 Jahre Erfahrung in der Forschung und Entwicklung in den Bereichen Genomik, Epigenetik, Biomarker, Bio-IT, komplexe Erkrankungen, und dem menschlichen Alterungsprozess. Er ist Autor des „Blockchain & Healthcare Strategy Guides“, dem Standard-Blockchain-Kompendium für die Gesundheitsbranche. Axel ist Fakultäts-Mitglied des Blockchain Research Institute in Toronto, dem weltweit führendem ThinkTank im Blockchain Bereich. Dr. Schumachers preisgekrönte Forschungen führte zu einem Durchbruch in der Entwicklung von Strategien zur personalisierten Medizin. Eine dieser Technologien, das sog. „epigenetische“ Microarray ist heute eine der Methoden der Wahl in der Industrie für die Biomarker-Forschung. Erstmals konnten epigenetische Muster im gesamten Genom des Menschen analysiert werden, wodurch auch das Verständnis für die Ausprägung von komplexen Erkrankungen wie Schizophrenie oder der Bipolaren Erkrankung deutlich voranschritt. Dr. Schumacher ist Entdecker ein neues biologisches Phänomen des Alterns, die sog. „epigenetische Drift“ in Gehirnen von Alzheimer Patienten. In 2017 gründete er eine globales Precision Medicine Unternehmen, Shivom.io, welches sich zum Ziel gesetzt hat den weltweit größten Data-Hub für Genom- und Gesundheitsdaten zu etablieren.

Maria Sievert

Maria Sievert

Maria Sievert

Founder & Managing Partner, inveox

Während ihres Studiums des Ingenieurwesens an der Technischen Universität München (TUM) sammelte Maria Sievert umfangreiche praktische Erfahrungen in verschiedenen Bereichen des Maschinenbaus. Nach Forschungsaufenthalten in den USA und Südamerika war sie als Projektleiterin im Bereich Digital Services bei BMW für das Innovationsmanagement verantwortlich.

2017 gründete sie gemeinsam mit dem Molekularbiotechnologen und Ökonomen Dominik Sievert die Firma inveox. Das Unternehmen hat ein innovatives Digitalisierungs- und Automatisierungssystem entwickelt, das die Effizienz von Labors und die Zuverlässigkeit von pathologischen Diagnosen deutlich erhöht.

Seit ihrer Gründung hat inveox zahlreiche Auszeichnungen und Stipendien erhalten, wurde zum StartUp des Jahres 2017 gewählt und ist auf der Forbes-Liste der »vielversprechendsten Start-ups 2018« vertreten.

Foto: Nathalie Zimmermann

Sebastian Sujka

Sebastian Sujka

Sebastian Sujka

Founder & CEO, xbird GmbH

Prof. Dr. Mario Voigt

Prof. Dr. Mario Voigt

Prof. Dr. Mario Voigt

Mitglied des Thüringer Landtages; Professor für Digitale Transformation und Politik, Quadriga Hochschule Berlin

Mario Voigt studierte Politikwissenschaft, Neuere Geschichte und Öffentliches Recht in Jena, Bonn und Charlottesville (USA). Danach promovierte er an der TU Chemnitz. Seine beruflichen Stationen waren SIEMENS European Union Affairs Brussels, die Konrad-Adenauer-Stiftung in Washington DC, Blueberry Consulting Jena und die Analytik Jena AG.

2009 und 2014 wurde er als Direktkandidat seines Wahlkreises im Saale-Holzland-Kreis im Thüringer Landtag gewählt. Seit 2017 lehrt und forscht Voigt neben seinem politischen Mandat als Professor für Digitale Transformation und Politik an der Quadriga Hochschule Berlin.

Dr. Stefan Weiss

Dr. Stefan Weiss

Dr. Stefan Weiss

Business Innovation Consultant, Zühlke Group

Dr. Stefan Weiss is Business Innovation Consultant at the Zühlke Group in Eschborn, Germany. He has a broad background in Neuroscience (PhD, Helmholtz Center Munich) combined with a profound expertise in economics and innovation management (MBA, Collège des Ingénieurs). Before joining Zühlke, Stefan shaped the future of Healthcare and Life Sciences at the Innovation Center of Merck KGaA. He is passionate about the digitalization of the Pharma- and MedTech Industry with innovative solutions and business models by applying his scientific and economic expertise. At Zühlke, he extends technical excellence with domain-specific insights and thereby strengthens the partnerships with Pharma- and MedTech customers.

Impressionen 2018

Premium-Partner

Partner

Netzwerkpartner

Medienpartner

Offizieller Druckpartner

In Zusammenarbeit mit dem Zeitverlag

Sprecher des Vorjahres (Auszug)

Dr. Boris Adryan

Dr. Boris Adryan

Dr. Boris Adryan

Chief Digital Officer / Expert for IoT & Data Analytics, Merck KGaA

Dr. Boris Adryan is a molecular biologist by training, with about 50 peer-reviewed publications in the life sciences. From 2008 to 2016 he was a Royal Society research group leader for computational genomics at the University of Cambridge, where he also taught data science and machine learning in an interdisciplinary degree programme. From 2014 his interests shifted to technology and connected products. In the meantime, Dr. Adryan has become an internationally renowned expert for IoT and M2M, and he is the lead author of „The Technical Foundations of IoT“ (Artech House, Boston/London). After a short stint as Head of IoT & Data Analytics at Zühlke Engineering GmbH, he is now acting as expert and consultant within the Chief Digital Office at chemical and pharmaceutical company Merck KGaA.

Herna Muñoz-Galeano

Herna Muñoz-Galeano

Herna Muñoz-Galeano

Managing Director, HMG Systems Engineering GmbH

Herna Muñoz-Galeano has over 25 years of experience in specification, development, integration and management of complex engineering systems. Since 1998, Herna has been an independent entrepreneur with a special interest in transforming science into innovative products and systems. She also has knowledge of standardization at ITU, ETSI and IEEE. She has perfected the methods which optimize the development process, including integration and testing processes, for breakthrough complex technical systems. By applying the “functional anatomy” method, all projects have been completed within the given time frame and budget Herna’s way of working is analytic and systematic and has made her who she is today. Respect, openness and trust are very important to her. Her employees and customers value her fast and logical judgment as well as her reliability and social competence. She is clientservice oriented and is always open for new challenges. Due to her international background, Herna Muñoz-Galeano speaks English and German fluently and Spanish is her native language. She has implemented projects in Germany, Sweden, Spain, the Netherlands, the United Kingdom and Brazil. Herna Muñoz-Galeano holds a master’s degree in Electronics Engineering from the Universidad Distrital Francisco José de Caldas in Bogotá, Colombia, and a master’s degree in Computer Science from the Friedrich-Alexander-University in Erlangen-Nuernberg, Germany. On 29th April 2016, Herna Muñoz-Galeano was awarded the Career Award “Engineer PowerWoman 2016” by the Deutsche Messe AG at the Hannover Messe. Since 1998, Herna has been an independent entrepreneur and managing director of HMG Systems Engineering GmbH, which emerged in 2014 from the merger of two other companies established by Herna. HMG Systems Engineering GmbH was awarded in 2016 as one of the Top 100 (top100.de) most innovative SMEs in Germany.

Dr. Yoshiyuki Sankai

Professor Dr. Yoshiyuki Sankai

Professor Dr. Yoshiyuki Sankai

CEO and President, CYBERDYNE, INC., Professor Dr., University of Tsukuba, Program Manager, ImPACT, promoted by Cabinet Office, Government of Japan

Yoshiyuki Sankai is a professor and Executive Research Director at the Center for Cybernics Research, University of Tsukuba; the President and CEO of CYBERDYNE, INC.; and a Program Manager of the Impulsing Paradigm Change through Disruptive Technologies (“ImPACT”) program, which was initiated by the Council for Science, Technology and Innovation (“CSTI”) of the Cabinet Office in Japan. He is a fellow of the Robotics Society of Japan (“RSJ”) and the Society of Instrument and Control Engineers (“SICE”) . He also served as Chairman and an Executive Board Member of Advanced Robotics. He is a member of Global Future Council on Human Enhancement of the World Economic Forum.
He has received numerous awards, including: The 2005 World Technology Award (World Technology Network), The 2012 Capek Award (INNOROBO), The 2014 Technology Pioneer (World Economic Forum), Gold Prize of 2014 Edison Awards, DealWatch Awards 2013 IPO of the Year (Thomson Reuters), DealWatch Awards 2014 Innovative Equity Deal of the Year (Thomson Reuters), The 2016 DIA Japan Outstanding Contribution to Health Award, the 7th Robot Award (Ministry of Health, Labour and Welfare award), and the Prime Minister’s Award (the third Nippon Venture Awards) in 2017.

Arantxa Unda

Arantxa Unda

Arantxa Unda

CEO, Sigesa

Projektmanager

Teilnehmermanagement

Veranstaltungsort

Sheraton Offenbach Hotel
Am Büsing Palais
Berliner Straße 111
63065 Offenbach / Frankfurt am Main

Sie verwenden einen sehr alten Browser. Um diese Website in vollem Umfang nutzen zu können, installieren Sie bitte einen aktuellen Browser. x